6.71
+0.055(+0.83%)
Currency In USD
| Previous Close | 6.65 |
| Open | 6.63 |
| Day High | 6.78 |
| Day Low | 6.63 |
| 52-Week High | 7.6 |
| 52-Week Low | 4.28 |
| Volume | 2,542 |
| Average Volume | 25,920 |
| Market Cap | 60.65M |
| PE | 23.95 |
| EPS | 0.28 |
| Moving Average 50 Days | 5.76 |
| Moving Average 200 Days | 6.02 |
| Change | 0.06 |
If you invested $1000 in ImmuCell Corporation (ICCC) 10 years ago, it would be worth $859.62 as of January 14, 2026 at a share price of $6.705. Whereas If you bought $1000 worth of ImmuCell Corporation (ICCC) shares 5 years ago, it would be worth $1,065.13 as of January 14, 2026 at a share price of $6.705.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
ImmuCell to Conduct Conference Call with Investors to Discuss Strategic Change in Focus
GlobeNewswire Inc.
Jan 07, 2026 1:10 PM GMT
Conference Call Scheduled for Friday, January 9, 2026 at 9:00 AM ETPORTLAND, Maine, Jan. 07, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health company that develops, manufactures and market
ImmuCell Announces Strategic Focus on First Defense® After Receiving an FDA Incomplete Letter for Re-Tain®
GlobeNewswire Inc.
Dec 24, 2025 6:05 PM GMT
PORTLAND, Maine, Dec. 24, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell”), an animal health company that develops, manufactures and markets products that improve cattle health and productivity today announced that it recei
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2025
GlobeNewswire Inc.
Nov 06, 2025 9:05 PM GMT
Conference Call Scheduled for Friday, November 14, 2025 at 9:00 AM ETPORTLAND, Maine, Nov. 06, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures a